Epidermolysis bullosa acquisita: What's new?

Journal of Dermatology

Volumn 37, Issue 3, 2010, Pages 220-230

  Ishii, Norito ^a   Hamada, Takahiro ^a   Dainichi, Teruki ^a   Karashima, Tadashi ^a   Nakama, Takekuni ^a   Yasumoto, Shinichiro ^a   Zillikens, Detlef ^b   Hashimoto, Takashi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Clinical manifestations; Epidermolysis bullosa acquisita; Pathogenesis; Therapy

Indexed keywords

AZATHIOPRINE; COLCHICINE; COLLAGEN TYPE 7; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; IMMUNOGLOBULIN; INFLIXIMAB; METHOTREXATE; RITUXIMAB;

CLINICAL FEATURE; DIARRHEA; DISEASE COURSE; EPIDERMOLYSIS BULLOSA ACQUISITA; HISTOPATHOLOGY; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOPATHOGENESIS; NONHUMAN; REVIEW; SKIN BIOPSY;

ADRENAL CORTEX HORMONES; ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; BASEMENT MEMBRANE; BLISTER; COLCHICINE; COLLAGEN TYPE VII; DAPSONE; EPIDERMOLYSIS BULLOSA ACQUISITA; EXTRACELLULAR MATRIX; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; SKIN;

EID: 77649203494     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2009.00799.x     Document Type: Review

References (98)

1. Robinson ND, Hashimoto T, Amagai M et al. Continuing medical education: the new pemphigus variants. J Am Acad Dermatol 1999 40 : 649 671.
2. Hashimoto T. Skin diseases related to abnormality in desmosomes and hemidesmosomes. J Dermatol Sci 1999 20 : 81 84.
3. Sitaru C, Goebeler M, Zillikens D. [Bullous autoimmune dermatoses (I): pathogenesis and diagnosis]. J Dtsch Dermatol Ges 2004 2 : 123 128.
4. Bystryn JC, Rudolph JL. Pemphigus. Lancet 2005 366 : 61 73.
5. Stanley JR, Amagai M. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med 2006 355 : 1800 1810.
6. Elliott GT. Two cases of epidermolysis bullosa. J Cutan Genitourin Dis 1895 13 : 10.
7. Roenigk HH, Ryan JG, Bergfeld WF. Epidermolysis bullosa acquisita: report of three cases and review of all published cases. Arch Dermatol 1971 103 : 1 10.
8. Kushniruk W. The immunopathology of epidermolysis bullosa acquisita. Can Med Assoc J 1973 108 : 1143 1146.
9. Richter BJ, McNutt NS. The spectrum of epidermolysis bullosa acquisita. Arch Dermatol 1979 115 : 1325 1328.
10. Palestine RF, Kossard S, Dicken CH. Epidermolysis bullosa acquisita: a heterogeneous disease. J Am Acad Dermatol 1981 5 : 43 53.
11. Zillikens D. Acquired skin disease of hemidesmosomes. J Dermatol Sci 1999 20 : 134 154.
12. Mihai S, Sitaru C. Immunopathology and molecular diagnosis of autoimmune bullous diseases. J Cell Mol Med 2007 11 : 462 481.
13. Woodley DT, Remington J, Chen M. Autoimmunity to type VII collagen: epidermolysis bullosa acquisita. Clin Rev Allergy Immunol 2007 33 : 78 84.
14. Zhu XJ, Niimi Y, Bystryn JC. Epidermolysis bullosa acquisita. Incidence in patients with basement membrane zone antibodies. Arch Dermatol 1990 126 : 171 174.
15. Bernard P, Vaillant L, Labeille B et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol 1995 131 : 48 52.
16. Gammon WR, Heise ER, Burke WA et al. Increased frequency of HLA DR2 in patients with autoantibodies to EBA antigen: evidence that the expression of autoimmunity to type VII collagen is HLA class II allele associated. J Invest Dermatol 1988 91 : 228 232.
17. Lee CW, Kim SC, Han H. Distribution of HLA class II alleles in Korean patients with epidermolysis bullosa acquisita. Dermatology 1996 193 : 328 329.
18. Hallel-Halevy D, Nadelman C, Chen M et al. Epidermolysis bullosa acquisita: update and review. Clin Dermatol 2001 19 : 712 718.
19. Engineer L, Ahmed AR. Emerging treatment for epidermolysis bullosa acquisita. J Am Acad Dermatol 2001 44 : 818 828.
20. Mutasim DF. Management of autoimmune bullous diseases: Pharmacology and therapeutics. J Am Acad Dermatol 2004 51 : 859 877.
21. Kirtschig G, Murrell D, Wojnarowska F et al. Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review. Arch Dermatol 2002 138 : 380 384.
22. Woodley DT, Briggaman RA, O'Keefe EJ et al. Identification of the skin basement- membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 1984 310 : 1007 1013.
23. Woodley DT, Burgeson RE, Lunstrum G et al. Epidermolysis bullosa acquisita antigen is the globular carboxyl terminus of type VII procollagen. J Clin Invest 1988 81 : 683 687.
24. Briggaman RA, Wheeler CE Jr. The epidermal-dermal junction. J Invest Dermatol 1975 65 : 71 84.
25. Keene DR, Sakai LY, Lunstrum GP et al. Type VII collagen forms an extended network of anchoring fibrils. J Cell Biol 1987 104 : 611 621.
26. Shimizu H, Ishiko A, Masunaga T et al. Most anchoring fibrils in human skin originate and terminate in the lamina densa. Lab Invest 1997 76 : 753 763.
27. Lapiere JC, Woodley DT, Parente MG et al. Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa. J Clin Invest 1993 92 : 1831 1839.
28. Gammon WR, Murrell DF, Jenison MW et al. Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the noncollagenous (NC1) domain. J Invest Dermatol 1993 100 : 618 622.
29. Tanaka T, Furukawa F, Imamura S. Epitope mapping for epidermolysis bullosa acquisita autoantibody by molecularly cloned cDNA for type VII collagen. J Invest Dermatol 1994 102 : 706 709.
30. Jones DA, Hunt SW III., Prisayanh PS et al. Immunodominant autoepitopes of type VII collagen are short, paired peptide sequences within the fibronectin type III homology region of the non-collagenous (NC1) domain. J Invest Dermatol 1995 104 : 231 235.
31. Sitaru C, Kromminga A, Hashimoto T et al. Autoantibodies to type VII collagen mediate Fcgamma-dependent granulocyte activation and induce dermal-epidermal separation in cryosections of human skin. Am J Pathol 2002 161 : 301 311.
32. Shimanovich I, Mihai S, Oostingh GJ et al. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J Pathol 2004 204 : 519 527.
33. Sitaru C, Mihai S, Otto C et al. Induction of dermal-epidermal separation in mice by passive transfer of antibodies to type VII collagen. J Clin Invest 2005 115 : 870 878.
34. Woodley DT, Chang C, Saadat P et al. Evidence that anti-type VII collagen antibodies are pathogenic and responsible for the clinical, histological, and immunological features of epidermolysis bullosa acquisita. J Invest Dermatol 2005 124 : 958 964.
35. Sitaru C, Chiriac MT, Mihai S et al. Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice. J Immunol 2006 177 : 3461 3468.
36. Sitaru C. Experimental models of epidermolysis bullosa acquisita. Exp Dermatol 2007 16 : 520 531.
37. Mihai S, Chiriac MT, Takahashi K et al. The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita. J Immunol 2007 178 : 6514 6521.
38. Chiriac MT, Roesler J, Sindrilaru A et al. NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage. J Pathol 2007 212 : 56 65.
39. Chan LS, Ahmed AR, Anhalt GJ et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 2002 138 : 370 379.
40. Gammon WR, Briggaman RA, Woodley DT et al. Epidermolysis bullosa acquisita: a pemphigoid- like disease. J Am Acad Dermatol 1984 11 : 820 832.
41. Dahl MG. Epidermolysis bullosa acquisita: a sign of cicatricial pemphigoid? Br J Dermatol 1979 101 : 475 484.
42. Gammon WR, Briggaman RA, Wheeler CE Jr. Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease. J Am Acad Dermatol 1982 7 : 382 387.
43. Kurzhals G, Stolz W, Meurer M et al. Acquired epidermolysis bullosa with the clinical features of Brunsting-Perry cicatricial bullous pemphigoid. Arch Dermatol 1991 127 : 391 395.
44. Hashimoto T, Ishiko A, Shimizu H et al. A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies. Br J Dermatol 1996 134 : 336 339. (Pubitemid 26053592)
45. Lee CW. Serum IgA autoantibodies in patients with epidermolysis bullosa acquisita: a high frequency of detection. Dermatology 2000 200 : 83 84.
46. Cox NH, Bearn MA, Herold J et al. Blindness due to the IgA variant of epidermolysis bullosa acquisita, and treatment with osteo-odonto- keratoprosthesis. Br J Dermatol 2007 156 : 775 777.
47. Mutasim DF, Bilic M, Hawayek LH et al. Immunobullous diseases. J Am Acad Dermatol 2005 52 : 1029 1043.
48. Tanaka N, Dainichi T, Ohyama B et al. A case of epidermolysis bullosa acquisita with clinical features of Brunsting-Perry pemphigoid showing an excellent response to colchicine. J Am Acad Dermatol 2009 61 : 715 719.
49. Tanaka H, Ishida-Yamamoto A, Hashimoto T et al. A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen. Lab Invest 1997 77 : 623 632.
50. Schmidt E, Hopfner B, Chen C et al. Childhood epidermolysis bullosa acquisita: a novel variant with reactivity to all three structural domains of type VII collagen. Br J Dermatol 2002 147 : 592 597.
51. Fukumoto T, Umemura T, Higuchi M et al. Childhood epidermolysis bullosa acquisita with autoantibodies against all 3 structural domains of type VII collagen. J Am Acad Dermatol 2004 50 : 480 482.
52. Mayuzumi M, Akiyama M, Nishie W et al. Childhood epidermolysis bullosa acquisita with autoantibodies against the noncollagenous 1 and 2 domains of type VII collagen: case report and review of the literature. Br J Dermatol 2006 155 : 1048 1052.
53. Chan LS, Lapiere JC, Chen M et al. Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. Arch Dermatol 1999 135 : 569 573.
54. Herrero-González JE, Mascaró JMJ, Herrero C et al. Autoantibodies from patients with BSLE inducing recruitment of leukocytes to the dermoepidermal junction and subepidermal splits in cryosections of human skin. Arch Dermatol 2006 142 : 1513 1516.
55. Shirahama S, Furukawa F, Yagi H et al. Bullous systemic lupus erythematosus: detection of antibodies against noncollagenous domain of type VII collagen. J Am Acad Dermatol 1998 38 : 844 848.
56. Chan L, Woodley D. Epidermolysis bullosa acquisita in the elderly. J Geriatr Dermatol 1995 4 : 47 52.
57. Krivo JM, Miller F. Immunopathology of epidermolysis bullosa acquisita. Association with mixed cryoglobulinemia. Arch Dermatol 1978 114 : 1218 1220.
58. Hoshina D, Sawamura D, Nomura T et al. Epidermolysis bullosa acquisita associated with psoriasis vulgaris. Clin Exp Dermatol 2007 32 : 516 518.
59. Endo Y, Tamura A, Ishikawa O et al. Psoriasis vulgaris coexistent with epidermolysis bullosa acquisita. Br J Dermatol 1997 137 : 783 786.
60. Kirtschig G, Chow ET, Venning VA et al. Acquired subepidermal bullous diseases associated with psoriasis: a clinical, immunopathological and immunogenetic study. Br J Dermatol 1996 135 : 738 745.
61. Sherry F, Dothridge MD. Case for diagnosis: epidermolysis bullosa acquisita. Proc R Soc Med 1962 55 : 409.
62. Ray TL, Levine JB, Weiss W et al. Epidermolysis bullosa acquisita and inflammatory bowel disease. J Am Acad Dermatol 1982 6 : 242 252.
63. Hughes BR, Horne J. Epidermolysis bullosa acquisita and total ulcerative colitis. J R Soc Med 1988 81 : 473 475.
64. Labeille B, Gineston J-L, Denoeux JP et al. Epidermolysis bullosa acquisita and Crohn's disease. Arch Intern Med 1988 148 : 1457 1459.
65. Chen M, O'Toole EA, Sanghavi J et al. The epidermolysis bullosa acquisita antigen (type VII collagen) is present in human colon and patients with crohn's disease have autoantibodies to type VII collagen. J Invest Dermatol 2002 118 : 1059 1064.
66. Woodley DT, Gammon WR, Briggaman RA. Epidermolysis bullosa acquisita. In : Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, Fitzpatrick TB, eds. Fitzpatrick's Dermatology in General Medicine, 4th edn. New York : McGraw-Hill, 1999 702 709.
67. Woodley DT, Briggaman RA, Gammon WR. Acquired epidermolysis bullosa. A bullous disease associated with autoimmunity to type VII (anchoring fibril) collagen. Dermatol Clin 1990 8 : 717 726.
68. Yaoita H, Briggaman RA, Lawley TJ, Provost TT, Katz SI. Epidermolysis bullosa acquisita: ultrastructural and immunological studies. J Invest Dermatol 1981 76 : 288 292.
69. Fine JD, Tyring S, Gammon WR. The presence of intralamina lucida blister formation in epidermolysis bullosa acquisita: possible role of leukocytes. J Invest Dermatol 1989 92 : 27 32.
70. Nieboer C, Boorsma DM, Woerdeman MJ et al. Epidermolysis bullosa acquisita. Immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients. Br J Dermatol 1980 102 : 383 392.
71. McMillan JR, Matsumura T, Hashimoto T et al. Immunomapping of EBA sera to multiple epitopes on collagen VII: further evidence that anchoring fibrils originate and terminate in the lamina densa. Exp Dermatol 2003 12 : 261 267.
72. Ishii N, Yoshida M, Hisamatsu Y et al. Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy. Br J Dermatol 2004 150 : 843 851.
73. Ishii N, Yoshida M, Ishida-Yamamoto A et al. Some epidermolysis bullosa acquisita sera react with epitopes within the triple-helical collagenous domain as indicated by immunoelectron microscopy. Br J Dermatol 2009 160 : 1090 1093.
74. Vodegel RM, de Jong MC, Pas HH et al. IgA-mediated epidermolysis bullosa acquisita: two cases and review of the literature. J Am Acad Dermatol 2002 47 : 919 925.
75. Gammon WR, Briggaman RA, Inman AO et al. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol 1984 82 : 139 144.
76. Gammon WR, Fine JD, Forbes M et al. Immunofluorescence on split skin for the detection and differentiation of basement membrane zone autoantibodies. J Am Acad Dermatol 1992 27 : 79 87.
77. Bernard P, Prost C, Aucouturier P et al. The subclass distribution of IgG autoantibodies in cicatricial pemphigoid and epidermolysis bullosa acquisita. J Invest Dermatol 1991 97 : 259 263.
78. Cho HJ, Lee IJ, Kim SC. Complement-fixing abilities and IgG subclasses of autoantibodies in epidermolysis bullosa acquisita. Yonsei Med J 1988 39 : 339 344.
79. Gandhi K, Chen M, Aasi S et al. Autoantibodies to type VII collagen have heterogenous subclass and light chain compositions and their complement- activating capacitities do not correlate with the inflammatory clinical phenotype. J Clin Immunol 2000 20 : 416 423.
80. Mooney E, Gammon WR. Heavy and light chain isotypes of immunoglobulin in epidermolysis bullosa acquisita. J Invest Dermatol 1990 95 : 317 319.
81. Wozniak K, Kowalewski C. Alterations of basement membrane zone in autoimmune subepidermal bullous diseases. J Dermatol Sci 2005 40 : 169 175.
82. Stanley JR, Rubinstein N, Klaus-Kovtun V. Epidermolysis bullosa acquisita antigen is synthesized by both human keratinocytes and human dermal fibroblasts. J Invest Dermatol 1985 85 : 542 545.
83. Chen M, Chan LS, Cai X et al. Development of an ELISA for rapid detection of anti-type VII collagen autoantibodies in epidermolysis bullosa acquisita. J Invest Dermatol 1997 108 : 68 72.
84. Jonkman MF, Schuur J, Dijk F et al. Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin alpha3. Arch Dermatol 2000 136 : 227 231.
85. Fairley JA, Woodley DT, Chen M et al. A patient with both bullous pemphigoid and epidermolysis bullosa acquisita: an example of intermolecular epitope spreading. J Am Acad Dermatol 2004 51 : 118 122.
86. Furukawa H, Miura T, Takahashi M et al. A case of anti-p200 pemphigoid with autoantibodies against both a novel 200-kD dermal antigen and the 290-kD epidermolysis bullosa acquisita antigen. Dermatology 2004 209 : 145 148.
87. Yamada T, Suzuki M, Koike Y et al. A case of epidermolysis bullosa acquisita with autoantibody to anti-p200 pemphigoid antigen and exfoliative esophagitis. Dermatology 2006 212 : 381 384.
88. Pastar Z, Rados J, Lipozencic J et al. Case of concurrent epidermolysis bullosa acquisita and anti-p200 pemphigoid - how to treat it? Int J Dermatol 2007 46 : 295 298.
89. Cunningham BB, Kirchmann TT, Woodley D. Colchicine for epidermolysis bullosa acquisita. J Am Acad Dermatol 1996 34 : 781 784.
90. Caldwell JB, Yancey KB, Engler RJ et al. Epidermolysis bullosa acquisita: efficacy of high-dose intravenous immunoglobulins. J Am Acad Dermatol 1994 31 : 827 828.
91. Mohr C, Sunderkotter C, Hildebrand A et al. Successful treatment of epidermolysis bullosa acquisita using intravenous immunoglobulins. Br J Dermatol 1995 132 : 824 826.
92. Kofler H, Wambacher-Gasser B, Topar G et al. Intravenous immunoglobulin treatment in therapy-resistant epidermolysis bullosa acquisita. J Am Acad Dermatol 1997 36 : 331 335.
93. Harman KE, Black MM. High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases. Br J Dermatol 1999 140 : 864 874.
94. Gourgiotou K, Exadaktylou D, Aroni K et al. Epidermolysis bullosa acquisita: treatment with intravenous immunoglobulins. J Eur Acad Dermatol Venereol 2002 16 : 77 80.
95. Campos M, Silvente C, Lecona M et al. Epidermolysis bullosa acquisita: diagnosis by fluorescence overlay antigen mapping and clinical response to high-dose intravenous immunoglobulin. Clin Exp Dermatol 2006 31 : 71 73.
96. Segura S, Iranzo P, Martínez DE et al. High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: evaluation of its use in 19 cases. J Am Acad Dermatol 2007 56 : 960 967.
97. Schmidt E, Benoit S, Bröcker EB et al. Successful adjuvant treatment of recalcitrant epidermolysis bullosa acquisita with anti-CD20 antibody rituximab. Arch Dermatol 2006 142 : 147 150.
98. Sadler E, Schafleitner B, Lanschuetzer C et al. Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab. Br J Dermatol 2007 157 : 417 419.